Omeros | OMER - Assets


Omeros reported $200.57M in Assets for its fiscal quarter ending in June of 2025.





Assets Change Date
Adma Biologics USD 684.21M 19.03M Jun/2026
Alnylam Pharmaceuticals USD 5.56B 429.22M Jun/2026
BioMarin Pharmaceutical USD 11.72B 3.13B Jun/2026
Cytokinetics USD 1.92B 651.07M Jun/2026
Gilead Sciences USD 49.36B 6.92B Jun/2026
Heron Therapeutics USD 252.26M 6.05M Jun/2026
Immunic USD 189.74M 165.69M Mar/2026
Insmed USD 2.1B 26.7M Jun/2026
Knight Therapeutics CAD 1.05B 2.28M Dec/2025
MacroGenics USD 345.41M 127.54M Jun/2026
Omeros USD 200.57M 34.59M Jun/2025
Pacira USD 1.24B 35.44M Jun/2026
Pfizer USD 201.13B 6.49B Jun/2026
Rockwell Medical USD 52.62M 1.34M Jun/2025
Sangamo BioSciences USD 97.56M 11.39M Jun/2025
Sarepta Therapeutics USD 3.19B 9.58M Jun/2026
United Therapeutics USD 7.22B 505.9M Jun/2026
Vertex Pharmaceuticals USD 27.42B 938.9M Jun/2026